Intermediate filament protein synemin is present in human reactive and malignant astrocytes and associates with ruffled membranes in astrocytoma cells

GLIA

Volumn 50, Issue 2, 2005, Pages 107-120

  Jing, Runfeng ^a   Pizzolato, Gianpaolo ^b   Robson, Richard M ^c   Gabbiani, Giulio ^b   Skalli, Omar ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c IOWA STATE UNIVERSITY   (United States)

Author keywords

actinin; Astrocyte; Cytoskeleton; Glioma; Intermediate filament; Synemin

Indexed keywords

ALPHA ACTININ; ALPHA SYNEMIN; BETA SYNEMIN; INTERMEDIATE FILAMENT PROTEIN; NOCODAZOLE; SYNEMIN; UNCLASSIFIED DRUG; VIMENTIN; ACTININ; CANCER ANTIBODY; DESMUSLIN; MUSCLE PROTEIN;

ARTICLE; ASTROCYTE; ASTROCYTOMA CELL; CARBOXY TERMINAL SEQUENCE; CELL MOTILITY; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WESTERN BLOTTING; ASTROCYTOMA; BIOSYNTHESIS; BRAIN LEVEL; BRAIN TUMOR; CELL MEMBRANE; CELL MOTION; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTININ; ANTIBODIES, NEOPLASM; ASTROCYTES; ASTROCYTOMA; BLOTTING, WESTERN; BRAIN CHEMISTRY; BRAIN NEOPLASMS; CELL MEMBRANE; CELL MOVEMENT; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INTERMEDIATE FILAMENT PROTEINS; MUSCLE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIMENTIN;

EID: 18244395587     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20158     Document Type: Article

References (65)

1. Bellin RM, Sernett SW, Becker B, Ip W, Huiatt TW, Robson RM. 1999. Molecular characteristics and interactions of the intermediate filament protein synemin. Interactions with alpha-actinin may anchor synemin-containing heterofilaments. J Biol Chem 274:29493-29499.
2. Bellin RM, Huiatt TW, Critchley DR, Robson RM. 2001. Synemin may function to directly link muscle cell intermediate filaments to both myofibrillar Z-lines and costameres. J Biol Chem 276:32330-32337.
3. Bigner DD, Bigner SH, Ponten J, Westermark B, Mahaley MS, Ruoslahti E, Herschman H, Eng LF, Wikstrand CJ. 1981. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 40:201-229.
4. Bilak SR, Sernett SW, Bilak MM, Bellin RM, Stromer MH, Huiatt TW, Robson RM. 1998. Properties of the novel intermediate filament protein synemin and its identification in mammalian muscle. Arch Biochem Biophys 355:63-76.
5. Borisy GG, Svitkina TM. 2000. Actin machinery: pushing the envelope. Curr Opin Cell Biol 12:104-112.
6. Bryan J. 1989. Caldesmon, acidic amino acids and molecular weight determinations. J Muscle Res Cell Motil 10:95-96.
7. Carlsson L, Li ZL, Paulin D, Price MG, Breckler J, Robson RM, Wiche G, Thornell LE. 2000. Differences in the distribution of synemin, paranemin, and plectin in skeletal muscles of wild-type and desmin knock-out mice. Histochem Cell Biol 114:39-47.
8. Coulombe PA, Ma L, Yamada S, Wawersik M. 2001. Intermediate filaments at a glance. J Cell Sci 114:4345-4347.
9. Dahlstrand J, Coffins VP, Lendahl U. 1992a. Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 52:5334-5341.
10. Dahlstrand J, Zimmerman LB, McKay RD, Lendahl U. 1992b. Characterization of the human nestin gene reveals a close evolutionary relationship to neurofilaments. J Cell Sci 103:589-597.
11. Debus E, Weber K, Osborn M. 1983. Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides. Differentiation 25:193-203.
12. Fliegner KH, Liem RK. 1991. Cellular and molecular biology of neuronal intermediate filaments. Int Rev Cytol 131:109-167.
13. Fuchs E, Weber K. 1994. Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 63:345-382.
14. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP. 1973. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51:1417-1423.
15. Hemken PM, Bellin RM, Sernett SW, Becker B, Huiatt TW, Robson RM. 1997. Molecular characteristics of the novel intermediate filament protein paranemin. Sequence reveals EAP-300 and IFAPa-400 are highly homologous to paranemin. J Biol Chem 272:32489-32499.
16. Hirako Y, Yamakawa H, Tsujimura Y, Nishizawa Y, Okumura M, Usukura J, Matsumoto H, Jackson KW, Owaribe K, Ohara O. 2003. Characterization of mammalian synemin, an intermediate filament protein present in all four classes of muscle cells and some neuroglial cells: co-localization and interaction with type III intermediate filament proteins and keratins. Cell Tissue Res 313:195-207.
17. Hsu SM, Raine L, Fanger H. 1981. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580.
18. Hutchison CJ, Alvarez-Reyes M, Vaughan OA. 2001. Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes? J Cell Sci 114:9-19.
19. Johnstone A, Thorpe R. 1996. Production of antibodies. In: Johnstone A, Thorpe R, editors. Immunohistochemistry in practice. 3rd ed. Cambridge: Blackwell Science, p 34-59.
20. Kachinsky AM, Dominov JA, Miller JB. 1995. Intermediate filaments in cardiac myogenesis: nestin in the developing mouse heart. J Histochem Cytochem 43:843-847.
21. Kleihues P, Burger PC, Scheithauer BW. 1993. The new WHO classification of brain tumours. Brain Pathol 3:255-268.
22. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
23. LeDizet M, Piperno G. 1991. Detection of acetylated alpha-tubulin by specific antibodies. Methods Enzymol 196:264-274.
24. Lee JA, Cole GJ. 2000. Localization of transitin mRNA, a nestin-like intermediate filament family member, in chicken radial glia processes. J Comp Neurol 418:473-483.
25. Lendahl U, Zimmerman LB, McKay RD. 1990. CNS stem cells express a new class of intermediate filament protein. Cell 60:585-595.
26. Lepekhin EA, Eliasson C, Berthold CH, Berezin V, Bock E, Pekny M. 2001. Intermediate filaments regulate astrocyte motility. J Neurochem 79:617-625.
27. Liedtke W, Edelmann W, Bieri PL, Chiu FC, Cowan NJ, Kucherlapati R, Raine CS. 1996. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17:607-615.
28. Liedtke W, Edelmann W, Chiu FC, Kucherlapati R, Raine CS. 1998. Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion. Am J Pathol 152:251-259.
29. Marvin MJ, Dahlstrand J, Lendahl U, McKay RD. 1998. A rod end deletion in the intermediate filament protein nestin alters its subcellular localization in neuroepithelial cells of transgenic mice. J Cell Sci 111:1951-1961.
30. Matsudaira P. 1994. Actin crosslinking proteins at the leading edge. Semin Cell Biol 5:165-174.
31. McCall MA, Gregg RG, Behringer RR, Brenner M, Delaney CL, Galbreath EJ, Zhang CL, Pearce RA, Chiu SY, Messing A. 1996. Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc Natl Acad Sci USA 93:6361-6366.
32. Mizuno Y, Thompson TG, Guyon JR, Lidov HG, Brosius M, Imamura M, Ozawa E, Watkins SC, Kunkel LM. 2001. Desmuslin, an intermediate filament protein that interacts with alpha-dystrobrevin and desmin. Proc Natl Acad Sci USA 98:6156-6161.
33. Nakamura F, Osborn E, Janmey PA, Stossel TP. 2002. Comparison of filamin A-induced cross-linking and Arp2/3 complex-mediated branching on the mechanics of actin filaments. J Biol Chem 277:9148-9154.
34. Nawashiro H, Messing A, Azzam N, Brenner M. 1998. Mice lacking GFAP are hypersensitive to traumatic cerebrospinal injury. NeuroReport 9:1691-1696.
35. Nawashiro H, Brenner M, Fukui S, Shima K, Hallenbeck JM. 2000. High susceptibility to cerebral ischemia in GFAP-null mice. J Cereb Blood Flow Metab 20:1040-1044.
36. Osborn M, Debus E, Weber K. 1984. Monoclonal antibodies specific for vimentin. Eur J Cell Biol 34:137-143.
37. Owens RB, Smith HS, Nelson-Rees WA, Springer EL. 1976. Epithelial cell cultures from normal and cancerous human tissues. J Natl Cancer Inst 56:843-849.
38. Pekny M, Eliasson C, Chien CL, Kindblom LG, Liem R, Hamberger A, Betsholtz C. 1998a. GFAP-deficient astrocytes are capable of stellation in vitro when cocultured with neurons and exhibit a reduced amount of intermediate filaments and an increased cell saturation density. Exp Cell Res 239:332-343.
39. Pekny M, Stanness KA, Eliasson C, Betsholtz C, Janigro D. 1998b. Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice. Glia 22:390-400.
40. Pekny M, Johansson CB, Eliasson C, Stakeberg J, Wallen A, Perlmann T, Lendahl U, Betsholtz C, Berthold CH, Frisen J. 1999. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J Cell Biol 145:503-514.
41. Pollard TD, Beltzner CC. 2002. Structure and function of the Arp2/3 complex. Curr Opin Struct Biol 12:768-774.
42. Porter RM, Holme TC, Newman EL, Hopwood D, Wilkinson JM, Cuschieri A. 1993. Monoclonal antibodies to cytoskeletal proteins: an immunohistochemical investigation of human colon cancer. J Pathol 170:435-440.
43. Prahlad V, Yoon M, Moir RD, Vale RD, Goldman RD. 1998. Rapid movements of vimentin on microtubule tracks: kinesin-dependent assembly of intermediate filament networks. J Cell Biol 143:159-170.
44. Price MG, Lazarides E. 1983. Expression of intermediate filament-associated proteins paranemin and synemin in chicken development. J Cell Biol 97:1860-1874.
45. Privat A, Gimenez-Ribotta M, Ridet J. 1995. Morphology of astrocytes. In: Kettenmann H, Ransom B, editors. Neuroglia. Oxford: Oxford University Press. p 3-22.
46. Rutka JT, Smith SL. 1993. Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: analysis of expression, proliferation, and tumorigenicity. Cancer Res 53:3624-3631.
47. Rutka JT, Hubbard SL, Fukuyama K, Matsuzawa K, Dirks PB, Becker LE. 1994. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells. Cancer Res 54:3267-3272.
48. Rutka JT, Murakami M, Dirks PB, Hubbard SL, Becker LE, Fukuyama K, Jung S, Tsugu A, Matsuzawa K. 1997. Role of glial filaments in cells and tumors of glial origin: a review. J Neurosurg 87:420-430.
49. Sambrook J, Russel D. 2001. Molecular cloning, a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
50. Schnitzer J, Franke WW, Schachner M. 1981. Immunocytochemical demonstration of vimentin in astrocytes and ependymal cells of developing and adult mouse nervous system. J Cell Biol 90:435-447.
51. Sejersen T, Lendahl U. 1993. Transient expression of the intermediate filament nestin during skeletal muscle development. J Cell Sci 106:1291-300.
52. Shaw G, Osborn M, Weber K. 1981. An immunofluorescence microscopical study of the neurofilament triplet proteins, vimentin and glial fibrillary acidic protein within the adult rat brain. Eur J Cell Biol 26:68-82.
53. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
54. Steinert PM, Chou YH, Prahlad V, Parry DA, Marekov LN, Wu KC, Jang SI, Goldman RD. 1999. A high molecular weight intermediate filament-associated protein in BHK-21 cells is nestin, a type VI intermediate filament protein. Limited co-assembly in vitro to form heteropolymers with type III vimentin and type IV alpha-internexin. J Biol Chem 274:9881-9890.
55. Sultana S, Zhou R, Sadagopan MS, Skalli O. 1998. Effects of growth factors and basement membrane proteins on the phenotype of U-373 MG glioblastoma cells as determined by the expression of intermediate filament proteins. Am J Pathol 153:1157-1168.
56. Sultana S, Sernett SW, Bellin RM, Robson RM, Skalli O. 2000. Intermediate filament protein synemin is transiently expressed in a subset of astrocytes during development. Glia 30:143-153.
57. Titeux M, Brocheriou V, Xue Z, Gao J, Pellissier JF, Guicheney P, Paulin D, Li Z. 2001. Human synemin gene generates splice variants encoding two distinct intermediate filament proteins. Eur J Biochem 268:6435-6449.
58. Toda M, Miura M, Asou H, Toya S, Uyemura K. 1994. Cell growth suppression of astrocytoma C6 cells by glial fibrillary acidic protein cDNA transfection. J Neurochem 63:1975-1978.
59. Tohyama T, Lee VM, Rorke LB, Marvin M, McKay RD, Trojanowski JQ. 1992. Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest 66:303-313.
60. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
61. Weinstein DE, Shelanski ML, Liem RK. 1991. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol 112:1205-1213.
62. Yen SH, Fields KL. 1981. Antibodies to neurofilament, glial filament, and fibroblast intermediate filament proteins bind to different cell types of the nervous system. J Cell Biol 88:115-126.
63. Yuan Y, Lee JA, Napier A, Cole GJ. 1997. Molecular cloning of a new intermediate filament protein expressed by radial glia and demonstration of alternative splicing in a novel heptad repeat region located in the carboxy-terminal tail domain. Mol Cell Neurosci 10:71-86.
64. Zhou R, Skalli O. 2000. Identification of cadherin-11 down-regulation as a common response of astrocytoma cells to transforming growth factor-alpha. Differentiation 66:165-172.
65. Zhou R, Wu X, Skalli O. 2002. The hyaluronan receptor RHAMM/IHABP in astrocytoma cells: expression of a tumor-specific variant and association with microtubules. J Neurooncol 59:15-26.